$100.10
2.602.67%
Last update: Oct 6, 7:29 AM
$100.20
2.702.77%
Abbott Laboratories
ABTNYSE
Abbott Laboratories (ABT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Abbott Laboratories (ABT) last issued guidance on July 16, 2026 for Q3 2026. The company guided earnings per share in the range of $1.38 - $1.46, compared to a consensus EPS estimate of $1.42.
Compared to prior guidance, Abbott Laboratories lowered its EPS outlook from a previous range of $5.45 - $5.6.
Abbott Laboratories has issued 27 guidance updates between October 19, 2022 and July 16, 2026. During this period, the company raised its outlook 6 times and lowered it 10 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.28 | $1.14 | $1.50 | $1.30 |
| Actual | $1.31 | $1.15 | $1.50 | $1.30 |
| Surprise | +2.34% | +0.88% | 0.00% | 0.00% |
| Revenue | ||||
| Estimate | $12.51B | $11.01B | $11.80B | $11.40B |
| Actual | $12.59B | $11.16B | $11.46B | $11.37B |
| Surprise | +0.66% | +1.43% | -2.87% | -0.30% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.42 | $1.64 | $1.30 | $1.49 |
| Revenue | ||||
| Consensus | $12.98B | $13.52B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 16, 2026 | $1.31 | $1.28 | 2.34 % |
| Q1 | Apr 16, 2026 | $1.15 | $1.14 | 0.88 % |
| Q4 | Jan 22, 2026 | $1.50 | $1.50 | 0.00 % |
| Q3 | Oct 15, 2025 | $1.30 | $1.30 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 16, 2026 | $12.59B | $12.51B | 0.66 % |
| Q1 | Apr 16, 2026 | $11.16B | $11.01B | 1.43 % |
| Q4 | Jan 22, 2026 | $11.46B | $11.80B | -2.87 % |
| Q3 | Oct 15, 2025 | $11.37B | $11.40B | -0.30 % |
